1 / 31

Global Regenerative Medicine Market Analysis - FY25

According to the MarkNtel Advisors research report, the Global Regenerative Medicine market is anticipated to grow at a CAGR of around 21.5% during 2020-25.

Sonu22
Download Presentation

Global Regenerative Medicine Market Analysis - FY25

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. marknteladvisors.com Global Regenerative Medicine Market Analysis, 2020

  2. Document Outline Introduction About Us, Key Questions Answered In This Study 02 Table of Content Market Segmentation, Scope of Work 05 Research Process & Methodology Primary Research, Secondary Research, Companies Interviewed, Respondent Profile, Research Methodology, Forecasting 20 Sample Pages Global Regenerative Medicine Market Analysis, 2020 28 60 Commercials 62 Disclaimer 2 Copyright 2020. Reproduction is forbidden unless authorized. All rights reserved.

  3. Market Segmentation Global Regenerative Medicine Market Segmentation By Type By Application By Company By Region • Musculoskeletal • Novartis • North America o Japan • Cell Based Immunotherapy & Cell Disorders • Vericel o The US o India Therapy Products • Wound Care • Stryker o Canada o South Korea o Allogenic Products • Oncology • Wright Medical o Mexico o Australia o Autologous Products • Diabetes • Pfizer • Europe o Others • Tissue Engineered Products • Dermatology • Abbott o The UK • South America o Scaffolds • Ophthalmology • AstraZenca o France o Brazil o Other Tissue Engineered • Bone Graft • Astellas Pharma o Germany o Argentina Products Substitute • Osiris Therapeutics o Spain o Others • Small Molecule and Biologics • MimedxGroup o Italy • Middle East & • Organogenesis o The Africa • Athersys Netherland o UAE o Others o Saudi Arabia • Asia-Pacific o South Africa o China o Others 3 Copyright 2020. Reproduction is forbidden unless authorized. All rights reserved.

  4. Historical Year: 2015 Base Year: 2019 Table of Content (1/13) Forecast Year: 2025 Table of Content 1. Introduction 1.1. Product Definition 1.2. Research Process 1.3. Glossary 1.4. Market Segmentation 2. Executive Summary 3. Global Regenerative Medicine Startup Ecosystem 3.1. Prominent Start-ups in Regenerative Medicine Market 3.2. Regenerative Medicine Funding Deals Vs Dollars 3.3. Funding Environment 3.3.1. Active Venture Capital Investors in Regenerative Medicine Market 3.3.1.1. Portfolio Description 3.3.1.2. Investments Across Start-ups 3.3.1.3. Total Funding Under Various Rounds 3.3.1.4. Future Plans and Potential Targets 3.3.2. Initial Public Offerings (IPOs) 3.3.3. Mergers & Acquisitions 3.3.4. Other Funding Under Categories 3.3.4.1. Conditioning Agents 3.3.4.2. Non-Aging Stem Cells 4 Copyright 2020. Reproduction is forbidden unless authorized. All rights reserved.

  5. Historical Year: 2015 Base Year: 2019 Table of Content (2/13) Forecast Year: 2025 Table of Content 3.3.4.3. Therapeutics 4. Global Regenerative Medicine Market Landscape 5. Impact of COVID-19 on Regenerative Medicine Startup Ecosystem 6. Expert Verbatim- Interview Excerpts of 10 industry experts 7. Global Regenerative Medicine Market Outlook, 2015-2025F 7.1. Market Size & Analysis 7.1.1. By Revenues 7.2. Market Share & Analysis 7.2.1. By Type 7.2.1.1. Cell Based Immunotherapy & Cell Therapy Products 7.2.1.1.1. Allogenic Products 7.2.1.1.2. Autologous Products 7.2.1.2. Tissue Engineered Products 7.2.1.2.1. Scaffolds 7.2.1.2.2. Other Tissue Engineered Products 7.2.1.3. Small Molecule and Biologics 7.2.2. By Application 7.2.2.1. Musculoskeletal Disorders 7.2.2.2. Wound Care 7.2.2.3. Oncology 5 Copyright 2020. Reproduction is forbidden unless authorized. All rights reserved.

  6. Historical Year: 2015 Base Year: 2019 Table of Content (3/13) Forecast Year: 2025 Table of Content 7.2.2.4. Diabetes 7.2.2.5. Dermatology 7.2.2.6. Ophthalmology 7.2.2.7. Bone Graft Substitute 7.2.3. By Region 7.2.3.1. North America 7.2.3.2. South America 7.2.3.3. Europe 7.2.3.4. Asia-Pacific 7.2.3.5. Middle East & Africa 7.2.4. By Company 7.2.4.1. Revenue Shares 7.2.4.2. Strategic Factorial Indexing 7.2.4.3. Competitor Placement in MarkNtel Quadrant 7.2.5. Market Attractiveness Index 7.2.5.1. By Type 7.2.5.2. By Application 7.2.5.3. By Region 8. North America Regenerative Medicine Market Outlook, 2015-2025F 8.1. Market Size & Analysis 6 Copyright 2020. Reproduction is forbidden unless authorized. All rights reserved.

  7. Historical Year: 2015 Base Year: 2019 Table of Content (4/13) Forecast Year: 2025 Table of Content 8.1.1. By Revenues 8.2. Market Share & Analysis 8.2.1. By Type 8.2.2. By Application 8.2.3. By Country 8.2.3.1. US 8.2.3.2. Canada 8.2.3.3. Mexico 8.3. The US Regenerative Medicine Market Outlook, 2015-2025F 8.3.1. Market Size & Analysis 8.3.1.1. By Revenues 8.3.2. Market Share & Analysis 8.3.2.1. By Type 8.3.2.2. By Application 8.4. Canada Regenerative Medicine Market Outlook, 2015-2025F 8.4.1. Market Size & Analysis 8.4.1.1. By Revenues 8.4.2. Market Share & Analysis 8.4.2.1. By Type 8.4.2.2. By Application 7 Copyright 2020. Reproduction is forbidden unless authorized. All rights reserved.

  8. Historical Year: 2015 Base Year: 2019 Table of Content (5/13) Forecast Year: 2025 Table of Content 8.5. Mexico Regenerative Medicine Market Outlook, 2015-2025F 8.5.1. Market Size & Analysis 8.5.1.1. By Revenues 8.5.2. Market Share & Analysis 8.5.2.1. By Type 8.5.2.2. By Application 9. South America Regenerative Medicine Market Outlook, 2015-2025F 9.1. Market Size & Analysis 9.1.1. By Revenues 9.2. Market Share & Analysis 9.2.1. By Type 9.2.2. By Application 9.2.3. By Country 9.2.3.1. Brazil 9.2.3.2. Argentina 9.2.3.3. Others 9.3. Brazil Regenerative Medicine Market Outlook, 2015-2025F 9.3.1. Market Size & Analysis 9.3.1.1. By Revenues 9.3.2. Market Share & Analysis 8 Copyright 2020. Reproduction is forbidden unless authorized. All rights reserved.

  9. Historical Year: 2015 Base Year: 2019 Table of Content (6/13) Forecast Year: 2025 Table of Content 9.3.2.1. By Type 9.3.2.2. By Application 9.4. Argentina Regenerative Medicine Market Outlook, 2015-2025F 9.4.1. Market Size & Analysis 9.4.1.1. By Revenues 9.4.2. Market Share & Analysis 9.4.2.1. By Type 9.4.2.2. By Application 10. Europe Regenerative Medicine Market Outlook, 2015-2025F 10.1. Market Size & Analysis 10.1.1. By Revenues 10.2. Market Share & Analysis 10.2.1. By Type 10.2.2. By Application 10.2.3. By Country 10.2.3.1. The UK 10.2.3.2. Germany 10.2.3.3. France 10.2.3.4. Italy 10.2.3.5. Spain 9 Copyright 2020. Reproduction is forbidden unless authorized. All rights reserved.

  10. Historical Year: 2015 Base Year: 2019 Table of Content (7/13) Forecast Year: 2025 Table of Content 10.2.3.6. The Netherland 10.2.3.7. Others 10.3. The UK Regenerative Medicine Market Outlook, 2015-2025F 10.3.1. Market Size & Analysis 10.3.1.1. By Revenues 10.3.2. Market Share & Analysis 10.3.2.1. By Type 10.3.2.2. By Application 10.4. Germany Regenerative Medicine Market Outlook, 2015-2025F 10.4.1. Market Size & Analysis 10.4.1.1. By Revenues 10.4.2. Market Share & Analysis 10.4.2.1. By Type 10.4.2.2. By Application 10.5. France Regenerative Medicine Market Outlook, 2015-2025F 10.5.1. Market Size & Analysis 10.5.1.1. By Revenues 10.5.2. Market Share & Analysis 10.5.2.1. By Type 10.5.2.2. By Application 10 Copyright 2020. Reproduction is forbidden unless authorized. All rights reserved.

  11. Historical Year: 2015 Base Year: 2019 Table of Content (8/13) Forecast Year: 2025 Table of Content 10.6. Italy Regenerative Medicine Market Outlook, 2015-2025F 10.6.1. Market Size & Analysis 10.6.1.1. By Revenues 10.6.2. Market Share & Analysis 10.6.2.1. By Type 10.6.2.2. By Application 10.7. Spain Regenerative Medicine Market Outlook, 2015-2025F 10.7.1. Market Size & Analysis 10.7.1.1. By Revenues 10.7.2. Market Share & Analysis 10.7.2.1. By Type 10.7.2.2. By Application 10.8. The Netherlands Regenerative Medicine Market Outlook, 2015-2025F 10.8.1. Market Size & Analysis 10.8.1.1. By Revenues 10.8.2. Market Share & Analysis 10.8.2.1. By Type 10.8.2.2. By Application 11. Asia-Pacific Regenerative Medicine Market Outlook, 2015-2025F 11.1. Market Size & Analysis 11 Copyright 2020. Reproduction is forbidden unless authorized. All rights reserved.

  12. Historical Year: 2015 Base Year: 2019 Table of Content (9/13) Forecast Year: 2025 Table of Content 11.1.1. By Revenues 11.2. Market Share & Analysis 11.2.1. By Type 11.2.2. By Application 11.2.3. By Country 11.2.3.1. China 11.2.3.2. India 11.2.3.3. Japan 11.2.3.4. Australia 11.2.3.5. South Korea 11.2.3.6. Others 11.3. China Regenerative Medicine Market Outlook, 2015-2025F 11.3.1. Market Size & Analysis 11.3.1.1. By Revenues 11.3.2. Market Share & Analysis 11.3.2.1. By Type 11.3.2.2. By Application 11.4. India Regenerative Medicine Market Outlook, 2015-2025F 11.4.1. Market Size & Analysis 11.4.1.1. By Revenues 12 Copyright 2020. Reproduction is forbidden unless authorized. All rights reserved.

  13. Historical Year: 2015 Base Year: 2019 Table of Content (10/13) Forecast Year: 2025 Table of Content 11.4.2. Market Share & Analysis 11.4.2.1. By Type 11.4.2.2. By Application 11.5. Japan Regenerative Medicine Market Outlook, 2015-2025F 11.5.1. Market Size & Analysis 11.5.1.1. By Revenues 11.5.2. Market Share & Analysis 11.5.2.1. By Type 11.5.2.2. By Application 11.6. Australia Regenerative Medicine Market Outlook, 2015-2025F 11.6.1. Market Size & Analysis 11.6.1.1. By Revenues 11.6.2. Market Share & Analysis 11.6.2.1. By Type 11.6.2.2. By Application 11.7. South Korea Regenerative Medicine Market Outlook, 2015-2025F 11.7.1. Market Size & Analysis 11.7.1.1. By Revenues 11.7.2. Market Share & Analysis 11.7.2.1. By Type 13 Copyright 2020. Reproduction is forbidden unless authorized. All rights reserved.

  14. Historical Year: 2015 Base Year: 2019 Table of Content (11/13) Forecast Year: 2025 Table of Content 11.7.2.2. By Application 12. Middle East & Africa Regenerative Medicine Market Outlook, 2015-2025F 12.1. Market Size & Analysis 12.1.1. By Revenues 12.2. Market Share & Analysis 12.2.1. By Type 12.2.2. By Application 12.2.3. By Country 12.2.3.1. UAE 12.2.3.2. Saudi Arabia 12.2.3.3. Others 12.3. UAE Regenerative Medicine Market Outlook, 2015-2025F 12.3.1. Market Size & Analysis 12.3.1.1. By Revenues 12.3.2. Market Share & Analysis 12.3.2.1. By Type 12.3.2.2. By Application 12.4. Saudi Arabia Regenerative Medicine Market Outlook, 2015-2025F 12.4.1. Market Size & Analysis 12.4.1.1. By Revenues 14 Copyright 2020. Reproduction is forbidden unless authorized. All rights reserved.

  15. Historical Year: 2015 Base Year: 2019 Table of Content (12/13) Forecast Year: 2025 Table of Content 12.4.2. Market Share & Analysis 12.4.2.1. By Type 12.4.2.2. By Application 12.5. South Africa Regenerative Medicine Market Outlook, 2015-2025F 12.5.1. Market Size & Analysis 12.5.1.1. By Revenues 12.5.2. Market Share & Analysis 12.5.2.1. By Type 12.5.2.2. By Application 13. Global Regenerative Medicine Dynamics 13.1. Drivers 13.2. Challenges 13.3. Impact Analysis 14. Global Regenerative Medicine Market Regulations, Product Standards 15. Global Regenerative Medicine Market Value Chain Analysis 16. Global Regenerative Medicine Market Intellectual Property Rights Analysis 17. Global Regenerative Medicine Market Hotspots & Opportunities 18. Global Regenerative Medicine Market Trends & Developments 19. Global Regenerative Medicine Market Key Strategic Imperatives for Success & Growth 20. Competition Outlook 15 Copyright 2020. Reproduction is forbidden unless authorized. All rights reserved.

  16. Historical Year: 2015 Base Year: 2019 Table of Content (13/13) Forecast Year: 2025 Table of Content 20.1. Competitor Wise Growth Strategies 20.1.1. Product Portfolio 20.1.2. Brand Specialization 20.1.3. Target Markets 20.1.4. Research & Development 20.1.5. Strategic Alliances & Initiatives 20.2. Company Profiles 20.2.1. Novartis 20.2.2. Vericel 20.2.3. Stryker 20.2.4. Wright Medical 20.2.5. Pfizer 20.2.6. Abbott 20.2.7. AstraZenca 20.2.8. Astellas Pharma 20.2.9. Osiris Therapeutics 20.2.10. MimedxGroup 20.2.11. Organogenesis 20.2.12. Athersys 21. Disclaimer 16 Copyright 2020. Reproduction is forbidden unless authorized. All rights reserved.

  17. Document Outline Introduction About Us, Key Questions Answered In This Study 02 Table of Content Market Segmentation, Scope Of Work 05 Research Process & Methodology Primary Research, Secondary Research, Companies Interviewed, Respondent Profile, Research Methodology, Forecasting 20 Sample Pages Global Regenerative Medicine Market Analysis, 2020 28 60 Commercials 62 Disclaimer 17 Copyright 2020. Reproduction is forbidden unless authorized. All rights reserved.

  18. Global Regenerative Medicine Startup Ecosystem Copyright 2020. Reproduction is forbidden unless authorized. All rights reserved.

  19. Global Regenerative Medicine Market Deals and Dollars 2015 2016 2017 20 30 50 40 15 20 30 10 20 10 5 10 0 0 0 Q1 Q2 Q3 Q4 Total Q1 Q2 Q3 Q4 Total Q1 Q2 Q3 Q4 Total Total Deals Funding Total Deals Funding Total Deals Funding Funding rose by more than 70% since Q4’19 2018 2019 2020 200 20 5 4 150 15 3 100 10 2 50 5 1 0 0 0 Q1 Q2 Q3 Q4 Total Q1 Q2 Q3 Q4 Total Q1 Q2 Total Deals Funding Total Deals Funding Total Deals Funding 19 Copyright 2020. Reproduction is forbidden unless authorized. All rights reserved.

  20. Global Regenerative Medicine Market Landscape Number of Regenerative Medicine Companies, By Region Regenerative Medicine Companies Region North America X Europe & Israel X Asia X Oceania X South America X Africa X Source: Alliance for Regenerative Medicine 20 Copyright 2020. Reproduction is forbidden unless authorized. All rights reserved.

  21. Global Regenerative Medicine Market Outlook, 2015-2025F Copyright 2020. Reproduction is forbidden unless authorized. All rights reserved.

  22. Global Regenerative Medicine Market Outlook, By Revenues Figure XX: Global Regenerative Medicine Market Revenues (USD Million), 2015- 2025F Revenue: XX% Revenue: XX% CAGR CAGR 2015 2016 2017 2018 2019 2020E 2021F 2022F 2023F 2024F 2025F Source: MarkNtel Advisors • The massive growth of global regenerative medicine market is attributed to the increasing number of patients diagnosed with chronic diseases such as diabetes, Alzheimer's disease, cancer, renal failure, spinal cord injury, etc. Alzheimer's disease is the 6thleading cause in the United States in 2020 and around 5 million individuals are living with Alzheimer's as per Alzheimer’s Association. The use of regenerative medicine is becoming popular and offers a complete cure for the disease. Therefore, the global regenerative medicine market is supposedto surge during the forecast years. • The launch of the Cures Act by Food and Drug Authority (FDA) in 2016, established the Regenerative Medicine Innovation Project (RMIP) to support the clinical research on adult stem cells. Thus the factor has been generating more demand for regenerative medicine from the past few years. 22 Copyright 2020. Reproduction is forbidden unless authorized. All rights reserved.

  23. Global Regenerative Medicine Market Revenue Share, By Type & By Tissue Engineered Products Figure XX: Global Regenerative Medicine Market Revenue Share (%), By Type, 2019 & 2025F • Cell Based Immunotherapy & Cell Therapy Products: This segment is expected to dominate the global market over the next 5 years. Technological advancements in stem cell therapies lead to an increase in demand for the treatment of cancer and diabetes patients across the globe. This is among the prime factors that contribute to the cell-based immunotherapy & cell therapy products segment. For instance, leukemia is being treated through haematogenic stem cells worldwide. • The several clinical trials are conducting in the Asia Pacific and North America region to treat COVID-19 through mesenchymal stem cells. This is expected to rise the segment in the coming years. *These are dummy charts and do not represent actual value 2019 2025F ▪ Tissue Engineered Products ▪ Small Molecule & Biologics ▪ Cell Based Immunotherapy & Cell Therapy Products Source: MarkNtel Advisors Figure XX: Global Regenerative Medicine Market Revenue Share (%), By Tissue Engineered Products, 2019 - 2025F Scaffolds Others 2019 2020 2021 2022 2023 2024 2025 Source: MarkNtel Advisors *These are dummy charts and do not represent actual value 23 Copyright 2020. Reproduction is forbidden unless authorized. All rights reserved.

  24. Global Regenerative Medicine Market Revenue Share, By Application Figure XX: Global Regenerative Medicine Market Revenue Share (%), By Application, 2019 & 2025F • Oncology: Oncology segment is estimated to grow at the maximum CAGR during 2020-25. Few factors supporting the segment are mentioned below: o The US is anticipated to record 1,806 thousand cancer cases in 2020 as per American cancer society. The large number of individuals diagnosed with requirement for effective cancer treatment, regenerative medicine is one of them. o The several private companies and government organizations have made a huge investment in the research and development of cancer regenerative and advanced cell therapies. Global efforts to decline the burden of cancer is estimated to boost the segment. o The large number of clinical trials conducted in oncology. According Regenerative Medicine, 62% of clinical trials have an oncology in 2019. Musculoskeletal Dsorder 2019 2025 XX% XX% Bone Graft Substitute Oncology 2019 2025 2019 2025 cancer is generating a XX% XX% XX% XX% 2019: Wound Care Ophthalmology USD XX Million 2019 2025 2019 2025 XX% XX% XX% XX% Dermatology Diabetes to the Alliance for 2019 2025 2019 2025 XX% XX% XX% XX% Source: MarkNtel Advisors 24 Copyright 2020. Reproduction is forbidden unless authorized. All rights reserved.

  25. Global Regenerative Medicine Market Revenue Share, By Region Figure XX: Global Regenerative Medicine Market Revenue Share (%), By Region, 2019 & 2025F 2019: X% 2025F: X% 2019: X% 2025F: X% 2019: X% 2025F: X% 2019: X% 2025F: X% 2019: X% 2025F: X% 2019: X% 2025F: X% Source: MarkNtel Advisors 25 Copyright 2020. Reproduction is forbidden unless authorized. All rights reserved.

  26. North America Regenerative Medicine Market Outlook, 2015-2025F Copyright 2020. Reproduction is forbidden unless authorized. All rights reserved.

  27. North America Regenerative Medicine Market Outlook, By Revenues Figure XX: North America Regenerative Medicine Market Revenues (USD Million), 2015- 2025F Revenue: XX% Revenue: XX% CAGR CAGR 2015 2016 2017 2018 2019 2020E 2021F 2022F 2023F 2024F 2025F Source: MarkNtel Advisors • North America regenerative medicine market is projected to dominate the global market over the next 5 years. The rising incidences of bone and joint injuries and growing awareness about regenerative medicine is anticipated to boost the regional market in the coming years. • The surging number of cosmetic surgical procedures in North America, particular in the US and Canada is anticipated to generate the demand for regenerative medicine during the forecast years. • The presence of research institutes and availability of the large number of players involved in research and development of novel therapeutics and the availability of advanced technologies are surging the number of clinical trials in the region. According to the Alliance for regenerative Medicine, 534 companies have shown presence in the development of regenerative medicine in North America. 27 Copyright 2020. Reproduction is forbidden unless authorized. All rights reserved.

  28. North America Regenerative Medicine Market Revenue Share, By Type & By Tissue Engineered Products Figure XX: North America Regenerative Medicine Market Revenue Share (%), By Type, 2019 & 2025F • Cell-based Immunotherapy & Cell Therapy Products: This segment is expected to grow at a maximum CAGR owing to the launched of Chimeric Antigen Receptor (CAR)-T-Cell Therapies. The rising demand for novel treatments for cancer coupled with increasing number of patients in the US and Canada is supporting the market share of this segment to grow from the past few years, o The American Cancer Society estimated 1.8 million new cancer cases to get diagnose in 2020. • The advancement in the healthcare system of North America is rising the adoption of gene therapy for the treatment of monogenic diseases, infectious diseases, etc. *These are dummy charts and do not represent actual value 2019 2025F ▪ Tissue Engineered Products ▪ Small Molecule & Biologics ▪ Cell Based Immunotherapy & Cell Therapy Products Figure XX: North America Regenerative Medicine Market Revenue Share (%), By Tissue Engineered Products, 2019 - 2025F Scaffolds Others 2019 2020 2021 2022 2023 2024 2025 Source: MarkNtel Advisors *These are dummy charts and do not represent actual value 28 Copyright 2020. Reproduction is forbidden unless authorized. All rights reserved.

  29. North America Regenerative Medicine Market Revenue Share, By Application Figure XX: North America Regenerative Medicine Market Revenue Share (%), By Application, 2019 & 2025F Musculoskeletal Dsorder 2019 2025 XX% XX% Bone Graft Substitute Oncology 2019 2025 2019 2025 XX% XX% XX% XX% 2019: Wound Care Ophthalmology USD XX Million 2019 2025 2019 2025 XX% XX% XX% XX% Dermatology Diabetes 2019 2025 2019 2025 XX% XX% XX% XX% Source: MarkNtel Advisors 29 Copyright 2020. Reproduction is forbidden unless authorized. All rights reserved.

  30. Global Regenerative Medicine Market Revenue Share, By Country Figure XX: Global Regenerative Medicine Market Revenue Share (%), By Country, 2019 & 2025F Canada United States ⚫ 2019: XX% ⚫ 2025F: XX% ⚫ 2019: XX% ⚫ 2025F: XX% Mexico ⚫ 2019: XX% ⚫ 2025F: XX% Source: MarkNtel Advisors 30 Copyright 2020. Reproduction is forbidden unless authorized. All rights reserved.

  31. +1 (613) 707-5086 sales@marknteladvisors.com 31 Copyright 2020. Reproduction is forbidden unless authorized. All rights reserved.

More Related